Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses

• Status: Withdrawn
• Trial end date: 2009-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the treatment of skin growths called actinic keratoses (AK) with 5-ALA PDT, an FDA-approved treatment, versus treatment with other conventionally used FDA-approved agents such as cryotherapy, Imiquimod, or 5-fluorouracil (5-FU).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Chicago
• Treatments: Aminolevulinic Acid; Imiquimod

Criteria

Inclusion Criteria:

• 18-95 years old

• Diagnosied with actinic keratoses.

Exclusion Criteria:

• Patients who have had Isotretinoin therapy less that 1 year prior to screening.

• Patients who have an adverse reaction to light exposure (for example photo- exacerbated seizures).

• History of porphyria